Evaluation of Symptomatic Peripheral Neuropathy in Type 2 Diabetes Mellitus and its Correlation with Other Microvascular Complications
Journal: International Journal of Science and Research (IJSR) (Vol.11, No. 5)Publication Date: 2022-05-05
Authors : Keertan Chinthamaduka; P. V. Makwana;
Page : 751-754
Keywords : Diabetic peripheral neuropathy; Diabetic Neuropathy examination scores (DNE); Michigan Neuropathy Screening Instrument (MNSI); Microvascular complications; risk factors;
Abstract
Diabetes-related complications affect many organ systems and are responsible for the majority of morbidity and mortality associated with the disease. They can be divided into vascular and non-vascular complications. The microvascular complications include retinopathy, neuropathy and nephropathy while the macrovascular complications include coronary artery disease, stroke and peripheral arterial disease. Methodology: A one-year cross sectional study was conducted in the Guru Gobind Singh Hospital, Jamnagar. 100 patient of type 2 diabetes with onset greater than35 years of age and patients who had symptoms of peripheral neuropathy were included in the study. Results: There is statistically significant correlation of diabetic neuropathy with other microvascular complications like diabetic retinopathy (Pless than0.05) and albuminuria (Pless than0.001). There was statistically significant correlation between diabetic peripheral neuropathy with age (pless than 0.05), duration of diabetes (Pless than0.05), HbA1C levels (Pless than0.05), systemic hypertension (Pless than0.001) and serum triglyceride levels (pless than0.05).
Other Latest Articles
- Synthetic Holization of the Nature and Type of Organizations Based on Philosophical Materialism
- Synthetic Holization of the Theory of Change of Organizations Based on Philosophical Materialism
- A Study on Consumer Perceptive on Home Loans Provided by Private Banks
- Smart Vermicomposting Control
- Clinical Validation of Effectiveness of Immunace Forte? & Ultra D3? Improving Immunogenicity of COVID-19 Vaccine in Healthy Individuals
Last modified: 2022-09-07 15:14:21